Celluma vs Dermalux: Full Head-to-Head Comparison

Both Celluma and Dermalux are FDA-cleared, clinically validated LED phototherapy devices used in professional settings. Both have published research supporting their efficacy. Both cost significantly more than consumer LED masks. And both are frequently compared by people trying to decide where to spend serious money on light therapy.

The comparison is not straightforward, because these devices solve the same problem — delivering therapeutic light to tissue — using fundamentally different engineering approaches, at very different price points, and for different use cases. This article breaks down the real differences so you can make an informed decision.

Affiliate disclosure: This page contains affiliate links. If you purchase through our links, we may earn a commission at no additional cost to you.

At a Glance

Feature	Celluma PRO	Dermalux Flex MD
Form factor	Flexible, conforms to body	Rigid panel on articulating arm
Blue wavelength	465 nm	415 nm
Red wavelength	640 nm	633 nm
Near-infrared	880 nm	830 nm
LED count	288	1,800+
Irradiance	15–30 mW/cm²	60–105 mW/cm²
Treatment time	30 min	12–20 min
FDA cleared	Yes	Yes
CE marked	Yes	Yes
Target user	Home + small clinic	Professional clinic
Price	£1,200–1,500	£5,000–8,000

Bottom line up front: Celluma is for serious home users and small clinics on a budget. Dermalux is for professional clinics where throughput and maximum irradiance matter. If you’re a home user, Celluma is the answer — Dermalux at £5,000+ doesn’t make sense outside a commercial setting.

Design Philosophy

Celluma: Flexibility as the Core Principle

Celluma’s defining feature is its flexible polycarbonate construction. The panels bend and wrap around body surfaces — a shoulder, a knee, the lower back. This design addresses a real physics problem: flat panels deliver uneven dose distribution to curved anatomy, and the further you move from the panel surface, the more irradiance drops.

By conforming to the body, Celluma keeps its LEDs closer to the skin across a broader surface area. The trade-off is that the panel doesn’t hold its shape independently — you need to position it and hold it in place, either by lying on it, draping it over the area, or using straps.

Dermalux: Fixed-Position Clinical Design

Dermalux uses rigid, fixed-position LED panels mounted on articulating arms. The panel is positioned above or alongside the patient at a consistent, measured distance. This is the standard design used in hospital dermatology departments and aesthetics clinics worldwide.

The clinical advantage is reproducibility: every treatment can be delivered at a defined distance with a defined irradiance. You know exactly how many joules per session. This precision is important for clinical trials and for clinic protocols where outcomes need to be consistent across practitioners and patients.

Wavelength Comparison

Both devices use a three-wavelength system covering blue, red, and near-infrared. But the specific wavelengths differ — and the differences matter.

Blue Light

Celluma: 465 nm vs Dermalux: 415 nm

The target for blue light therapy (primarily acne) is protoporphyrin IX, a compound produced by Cutibacterium acnes. Protoporphyrin IX absorbs light most strongly at approximately 415–417 nm. Dermalux’s 415 nm is precisely at this absorption peak.

Celluma’s 465 nm is in the blue range but further from the protoporphyrin IX absorption peak. It produces effects, but the dosing required to achieve equivalent bacterial inactivation is higher.

Advantage: Dermalux for acne-focused treatment.

Red Light

Celluma: 640 nm vs Dermalux: 633 nm

Both wavelengths fall within the primary cytochrome c oxidase absorption band and are therapeutically effective for skin rejuvenation and collagen stimulation. The difference of 7 nm is clinically minor — the primary studies on red light for anti-ageing (Wunsch & Matuschka, 2014) used 633 nm, which gives Dermalux a marginal literature alignment advantage, but this is unlikely to translate to meaningfully different outcomes.

Advantage: Marginal Dermalux, effectively negligible in practice.

Near-Infrared

Celluma: 880 nm vs Dermalux: 830 nm

Near-infrared wavelengths target deeper tissue — joints, muscles, tendons. The 830 nm wavelength has a stronger evidence base and is closer to the 810–830 nm range used in the majority of deep tissue and pain management studies. Celluma’s 880 nm sits further from the main research cluster, though it remains within the therapeutic NIR window.

Advantage: Dermalux on evidence alignment.

Irradiance: The Critical Difference

This is where the gap between these devices is most significant.

Device	Irradiance	Session to deliver 20 J/cm²
Celluma PRO	15–30 mW/cm²	11–22 minutes
Dermalux Flex MD	60–105 mW/cm²	3–6 minutes

Dermalux delivers 3–5× the irradiance of Celluma. This means:

• Shorter sessions (12–20 min vs 30 min) for equivalent total dose
• Potentially faster clinical outcomes in high-dose-dependent conditions
• Greater ability to reach target doses for deep tissue treatment

For a clinic treating 8–10 patients per day, this difference is economically significant — shorter sessions mean more throughput. For a home user doing one session per day, 30 minutes versus 12 minutes is a lifestyle choice, not a clinical crisis.

However: The biphasic dose response means higher irradiance is not always better. For skin conditions (anti-ageing, acne), the optimal dose range (3–15 J/cm²) is achievable with either device within the session lengths each uses. The irradiance advantage matters most for deep tissue and for treatment throughput.

Clinical Evidence

Celluma

Celluma’s key published study is Ablon (2018) in Journal of Clinical and Aesthetic Dermatology — a controlled trial demonstrating significant improvement in facial wrinkles after 12 weeks of treatment with the Celluma device. The study was device-specific and well-controlled.

Celluma also benefits from the broader PBM literature supporting its wavelength choices (465 nm + 640 nm + 880 nm).

Dermalux

Dermalux has a larger body of published clinical research, partly because the devices have been in professional use for longer and the fixed-position design makes reproducible study conditions easier to achieve. Studies support efficacy across acne, anti-ageing, wound healing, and inflammatory skin conditions.

The Dermalux Tri-Wave MD (the clinic professional model) has published studies specifically on its 415/633/830 nm combination showing significant improvements in acne severity and skin quality.

Advantage: Dermalux on volume of evidence, though Celluma is well-supported for home use.

Price Analysis

Device	Price	Best For
Celluma PRO	£1,200–1,500	Home use or small clinic supplementary device
Celluma ELITE	£2,000–2,500	Higher-throughput small clinic
Dermalux Flex MD	£5,000–6,000	Professional clinic primary device
Dermalux Tri-Wave MD	£7,000–10,000	High-volume professional clinic

For home users, the Dermalux price range is essentially prohibitive. A Dermalux Flex MD costs the same as a reasonable second-hand car. Even for clinics, Dermalux represents a significant capital expense that needs to be justified by patient throughput and revenue.

Celluma at £1,200–1,500 occupies a prosumer/small clinic price point — expensive for casual home use but justifiable for serious home users or clinics with limited budgets.

Who Should Buy Celluma

• Home users who want a clinical-grade, FDA-cleared device for daily use — Celluma is the practical option
• Users treating both skin and musculoskeletal conditions — the flexible design genuinely helps for shoulders, knees, and lower back
• Small aesthetics clinics that want to offer LED treatments without committing to Dermalux pricing
• Acne patients who also have ageing concerns — the blue + red + NIR combination is uniquely versatile
• Anyone whose budget is under £2,000

Buy Celluma PRO on Amazon →{rel=“nofollow sponsored noopener noreferrer” target=“_blank”}

Who Should Buy Dermalux

• Professional clinics wanting the highest clinical credibility and irradiance for patient treatments
• Clinics where treatment throughput is a priority (shorter sessions per patient)
• Practitioners focused on acne treatment specifically, where 415 nm’s precision at the protoporphyrin IX absorption peak matters
• Clinics already charging £80–150 per LED session that need to justify premium positioning
• Anyone for whom £5,000+ is a proportionate investment relative to clinic revenue

The Honest Verdict

If you are a home user, buy Celluma. Dermalux at £5,000+ is a clinic device. Unless you are building a treatment room and charging patients, the economics don’t work.

If you are a clinic, the comparison becomes more nuanced. Celluma’s flexibility is a genuine clinical advantage for body treatments — patients with shoulder or knee conditions benefit from the contouring design. Dermalux wins on irradiance, wavelength precision, and session throughput for facial treatments. Many clinics use Dermalux as their primary facial device and Celluma (or equivalent flexible panels) for body work.

For anti-ageing specifically: both devices have clinical support, but Dermalux’s higher irradiance and shorter session times may translate to faster results for clinic patients. For acne: Dermalux’s 415 nm is more precisely targeted than Celluma’s 465 nm.

For 95% of readers asking “Celluma vs Dermalux”: the answer is Celluma — because Dermalux is priced for professional contexts that most readers don’t occupy.

---

This comparison is editorially independent. Product details and prices were accurate at the time of writing. See our Celluma PRO full review for the complete breakdown.